Citius Oncology (CTOR) Interest & Investment Income (2025 - 2026)
Citius Oncology's (CTOR) quarterly Interest & Investment Income came in at $43721.0 in Q1 2026, up 54.56% on a QoQ basis from $28288.0 in Q4 2025.
Citius Oncology (CTOR) Interest & Investment Income (2025 - 2026) Analysis & Trends
Citius Oncology (CTOR) has 2 years of Interest & Investment Income data on file, last reported at $43721.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 32.85 Mn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 41.80 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 28.10 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Citius Oncology | 56.52 Mn | 56.52 Mn | 1.34 Mn | 43,721.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43,721.00 |
| Dec 31, 2025 | 28,288.00 |